Vancomycin and daptomycin dosing recommendations in patients receiving home hemodialysis using Monte Carlo simulation

BMC Nephrology

Research

Soo Min Jang¹  Susan J. Lewis²  Bruce A. Mueller³ 

[1] Proacture Consulting Group, 6905 Telegraph Rd, 48304, Bloomfield Hills, MI, USA;University of Findlay College of Pharmacy, 1000 N. Main Street, 45840, Findlay, OH, USA;Mercy Health - St. Anne Hospital, 43623, Toledo, OH, USA;University of Michigan College of Pharmacy, 428 Church Street, 48109-1065, Ann Arbor, MI, USA;

关键词: Pharmacokinetics;    Pharmacodynamics;    Vancomycin;    Daptomycin;    Renal disease;    Home hemodialysis;    Monte Carlo simulation;   

DOI  :  10.1186/s12882-023-03314-y

 received in 2023-04-18, accepted in 2023-08-29,  发布年份 2023

来源: Springer

【 摘 要 】

BackgroundFew drug dosing recommendations for patients receiving home hemodialysis (HHD) have been published which has hindered the adoption of HHD. HHD regimens vary widely and differ considerably from conventional, thrice weekly, in-center hemodialysis in terms of treatment frequency, duration and blood and dialysate flow rates. Consequently, vancomycin and daptomycin clearances in HHD are also likely to be different, consequently HHD dosing regimens must be developed to ensure efficacy and minimize toxicity when these antibiotics are used. Many HHD regimens are used clinically, this study modeled ten common HHD regimens and determined optimal vancomycin and daptomycin dosing for each HHD regimen.MethodsMonte Carlo simulations using pharmacokinetic data derived from the literature and demographic data from a large HHD program treating patients with end stage kidney disease were incorporated into a one-compartment pharmacokinetic model. Virtual vancomycin and daptomycin doses were administered post-HHD and drug exposures were determined in 5,000 virtual patients receiving ten different HHD regimens. Serum concentration monitoring with subsequent dose changes was incorporated into the vancomycin models. Pharmacodynamic target attainment rates were determined for each studied dose. The lowest possible doses that met predefined targets in virtual patients were chosen as optimal doses.ResultsHHD frequency, total dialysate volumes and HHD durations influenced drug exposure and led to different dosing regimens to meet targets. Antibiotic dosing regimens were identified that could meet targets for 3- and 7-h HHD regimens occurring every other day or 4–5 days/week. HHD regimens with 3-day interdialytic periods required higher doses prior to the 3-day period. The addition of vancomycin serum concentration monitoring allowed for calculation of necessary dosing changes which increased the number of virtual subjects meeting pharmacodynamic targets.ConclusionsDoses of vancomycin and daptomycin that will meet desired pharmacodynamic targets in HHD are dependent on patient and HHD-specific factors. Doses used in conventional thrice weekly hemodialysis are unlikely to meet treatment goals. The antibiotic regimens paired with the HHD parameters studied in this analysis are likely to meet goals but require clinical validation.

【 授权许可】

CC BY   
© BioMed Central Ltd., part of Springer Nature 2023

【 图 表 】

Fig. 5

Fig. 3

40708_2023_201_Article_IEq9.gif

13690_2023_1170_Article_IEq217.gif